Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$869.9K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
1 of 8 filings we hold was filed after the two-business-day deadline. The furthest past the deadline was 5 business days late.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured
The 48 most recent Form 4 transactions.
| Gyre Therapeutics, INC. |
| MEXER |
| 3,000 |
| $0.75 |
| $2.3K |
| +0.4% |
| Open the original filing on SEC.gov |
| Jun 11 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 2,800 | — | — | — | Open the original filing on SEC.gov |
| Jun 11 | GYRE | Gyre Therapeutics, INC. | SSELL | 2,800 | $6.17 | $17.3K | -0.4% | Open the original filing on SEC.gov |
| Jun 11 | GYRE | Gyre Therapeutics, INC. | MEXER | 2,800 | $0.75 | $2.1K | +0.4% | Open the original filing on SEC.gov |
| Jun 10 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 6,418 | — | — | — | Open the original filing on SEC.gov |
| Jun 10 | GYRE | Gyre Therapeutics, INC. | SSELL | 6,418 | $6.21 | $39.9K | -0.9% | Open the original filing on SEC.gov |
| Jun 10 | GYRE | Gyre Therapeutics, INC. | MEXER | 6,418 | $0.75 | $4.8K | +0.9% | Open the original filing on SEC.gov |
| Jun 10 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 5,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 10 | GYRE | Gyre Therapeutics, INC. | SSELL | 5,000 | $6.24 | $31.2K | -0.7% | Open the original filing on SEC.gov |
| Jun 10 | GYRE | Gyre Therapeutics, INC. | MEXER | 5,000 | $0.75 | $3.8K | +0.7% | Open the original filing on SEC.gov |
| Jun 9 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 14,500 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | GYRE | Gyre Therapeutics, INC. | SSELL | 14,500 | $6.14 | $89K | -2.0% | Open the original filing on SEC.gov |
| Jun 9 | GYRE | Gyre Therapeutics, INC. | MEXER | 14,500 | $0.75 | $10.9K | +2.1% | Open the original filing on SEC.gov |
| Jun 9 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 3,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 9 | GYRE | Gyre Therapeutics, INC. | SSELL | 3,000 | $6.15 | $18.5K | -0.4% | Open the original filing on SEC.gov |
| Jun 9 | GYRE | Gyre Therapeutics, INC. | MEXER | 3,000 | $0.75 | $2.3K | +0.4% | Open the original filing on SEC.gov |
| Jun 5 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 15,401 | — | — | — | Open the original filing on SEC.gov |
| Jun 5 | GYRE | Gyre Therapeutics, INC. | SSELL | 15,401 | $6.40 | $98.6K | -2.1% | Open the original filing on SEC.gov |
| Jun 5 | GYRE | Gyre Therapeutics, INC. | MEXER | 15,401 | $0.75 | $11.6K | +2.2% | Open the original filing on SEC.gov |
| Jun 4 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 19,575 | — | — | — | Open the original filing on SEC.gov |
| Jun 4 | GYRE | Gyre Therapeutics, INC. | SSELL | 19,575 | $6.13 | $120K | -2.7% | Open the original filing on SEC.gov |
| Jun 4 | GYRE | Gyre Therapeutics, INC. | MEXER | 19,575 | $0.75 | $14.7K | +2.8% | Open the original filing on SEC.gov |
| May 26 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 4,000 | — | — | — | Open the original filing on SEC.gov |
| May 26 | GYRE | Gyre Therapeutics, INC. | SSELL | 4,000 | $6.10 | $24.4K | -0.6% | Open the original filing on SEC.gov |
| May 26 | GYRE | Gyre Therapeutics, INC. | MEXER | 4,000 | $0.75 | $3K | +0.6% | Open the original filing on SEC.gov |
| May 22 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 3,500 | — | — | — | Open the original filing on SEC.gov |
| May 22 | GYRE | Gyre Therapeutics, INC. | SSELL | 3,500 | $6.08 | $21.3K | -0.5% | Open the original filing on SEC.gov |
| May 22 | GYRE | Gyre Therapeutics, INC. | MEXER | 3,500 | $0.75 | $2.6K | +0.5% | Open the original filing on SEC.gov |
| May 21 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 12,820 | — | — | — | Open the original filing on SEC.gov |
| May 21 | GYRE | Gyre Therapeutics, INC. | SSELL | 12,820 | $6.15 | $78.8K | -1.8% | Open the original filing on SEC.gov |
| May 21 | GYRE | Gyre Therapeutics, INC. | MEXER | 12,820 | $0.75 | $9.6K | +1.8% | Open the original filing on SEC.gov |
| May 20 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 9,400 | — | — | — | Open the original filing on SEC.gov |
| May 20 | GYRE | Gyre Therapeutics, INC. | SSELL | 9,400 | $6.15 | $57.8K | -1.3% | Open the original filing on SEC.gov |
| May 20 | GYRE | Gyre Therapeutics, INC. | MEXER | 9,400 | $0.75 | $7.1K | +1.3% | Open the original filing on SEC.gov |
| May 19 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 9,120 | — | — | — | Open the original filing on SEC.gov |
| May 19 | GYRE | Gyre Therapeutics, INC. | SSELL | 9,120 | $6.37 | $58.1K | -1.3% | Open the original filing on SEC.gov |
| May 19 | GYRE | Gyre Therapeutics, INC. | MEXER | 9,120 | $0.75 | $6.8K | +1.3% | Open the original filing on SEC.gov |
| May 18 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 200 | — | — | — | Open the original filing on SEC.gov |
| May 18 | GYRE | Gyre Therapeutics, INC. | SSELL | 200 | $6.62 | $1.3K | <0.1% | Open the original filing on SEC.gov |
| May 18 | GYRE | Gyre Therapeutics, INC. | MEXER | 200 | $0.75 | $150 | +<0.1% | Open the original filing on SEC.gov |
| May 15 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 13,100 | — | — | — | Open the original filing on SEC.gov |
| May 15 | GYRE | Gyre Therapeutics, INC. | SSELL | 13,100 | $6.65 | $87.1K | -1.8% | Open the original filing on SEC.gov |
| May 15 | GYRE | Gyre Therapeutics, INC. | MEXER | 13,100 | $0.75 | $9.8K | +1.9% | Open the original filing on SEC.gov |
| May 14 | GYRE | Gyre Therapeutics, INC. | MEXER◆ | 15,580 | — | — | — | Open the original filing on SEC.gov |
| May 14 | GYRE | Gyre Therapeutics, INC. | SSELL | 15,580 | $6.91 | $107.7K | -2.2% | Open the original filing on SEC.gov |
| May 14 | GYRE | Gyre Therapeutics, INC. | MEXER | 15,580 | $0.75 | $11.7K | +2.2% | Open the original filing on SEC.gov |